){kind=logo}
Group
We are proud to be collaborating with our clinical, research, policy, economic, payer and business expertise as a Professional Learning Network – PLN.
Members of the Professional Learning Network group include former assessors at IQWIG, ex-members of the Commission de la Transparence, a former member of CADTH in Canada, an adviser to the central government and regional HTA bodies in Spain, a former member of the both the scientific and the reimbursement committee at AIFA, and a practicing oncologist and health economist – among others.
Susanne Michel, MD
Germany
Head of HTA Consulting and Evidence Planning, former Min of Health Berlin and Dept of Health England
Michael Epstein, MS
United States
Head of Commercial Strategy and Pricing, Business strategist and research specialist. Former Evidera senior principal
Derek van Amerongen, MD
United States
Expertise: US access and pricing; former VP and Medical Director, Humana
Kevin Knopf, MD
United States
Expertise: oncology, health economics; hospital Chief of Oncology and Health Services Researcher
Yukiko Asaeda, MD
Japan
Expertise: new product launch/commercialization in Japan, Japanese management experience, Japanese R&D: Eisai, BMS, Mundipharma and Novartis
Thomas Brauner, MBA
Germany
Expertise: health policy; former Head of Policy, German Ministry of Health
Marc Bardou, MD, PhD
France
Expertise: French national early access, HTA, and economic analysis; former Head, Temporary Authorisation Committee (Commmittee ATU), National Agency for the Safety of Medicines and Health Products (ANSM); former member, Transparency Commission; current member, Committee for the Economic Evaluation of Health Products (CEESP)
Isabelle Giri, PhD
France
Expertise: French national HTA and pricing; former Adviser, French Ministry of Health and Social Affairs; former member, Transparency committee (HAS)
Prof. Filippo Drago, MD, PhD
Italy
Expertise: Italian HTA & pricing; former member, Italian Medicines Agency (AIFA, both Technical Scientific Committee and Pricing & Reimbursement Committee); former member, regional HTA agency
Miguel Angel Calleja Hernandez, PharmD, PhD
Spain
Expertise: Spanish national HTA and pricing, regional and hospital decision making; Chief of the Pharmaceutical Service, Virgin Macarena University Hospital (Virgen de las Nieves from 2005 to 2016), former President of Spanish Society of Hospital Pharmacy (2015-2019), external expert for AEMPS, MoH and AETSA
Andres Navarro Ruiz, PharmD
Spain
Expertise: Spanish national HTA and pricing, regional and hospital decision making; Chief of the Pharmaceutical Service, General University Hospital of Elche; former member, regional HTA agency, Former president of Valencian Hospital Pharmacy Scientific Society, profesor of Universidad Miguel Hernandez de Elche.
Liu Hsiang, PharmD, MBA
Brazil
Expertise: marketing authorization, go-to-market, and commercialization in Brazil, Brazilian Management experiences: The Medicines Company, CSL Behring, Roche Diagnostics and Bayer.
Olaf Koester, MBA, RPh
Canada
Extensive, successful public service career: senior leadership roles at Manitoba Health (Acting Assistant Deputy Minister, Director Provincial Drug Programs, Director Blood Programs, Senior Consultant Provincial Oncology Programs, provincial Vaccine Immunization Committee); formerly Co-Chair, pCODR at CADTH, Chair of National Prescription Drug Utilization Information System (NPDUIS-PMPRB) Steering Committee, founding member of the pCPA, inaugural member of the Drug Safety and Effectiveness Network (DSEN), and Vice Chair, Pharmaceutical Directors Forum.
Marcus Schmitt-Egenolf, MD, PhD
Sweden
Expertise: Swedish HTA; adviser to Dental and Pharmaceutical Benefits Agency (TLV)